Results 151 to 160 of about 706,075 (298)

Drug Manipulation in Pediatric Care: A Scoping Review of a Widespread Practice Signaling Systemic Gaps in Pharmaceutical Provision. [PDF]

Pharmacy (Basel)
Vermehren C, Giraldi L, Al-Rubai S, Heerfordt IM, Merimi Y, Mathiasen R, Müllertz A, Andersen JT, Kaae S, Gade C.   +9 more
europepmc   +1 more source

Electron Manipulation and Surface Reconstruction of Bimetallic Iron–Nickel Phosphide Nanotubes for Enhanced Alkaline Water Electrolysis

Xinqiang Wang, Jinhao Zhou, Wen‐Gang Cui, Fan Gao, Yong Gao, Fulai Qi, Yanxia Liu, Xiaoying Yang, Ke Wang, Zhenglong Li, Yaxiong Yang, Jian Chen, Wenping Sun, Lixian Sun, Hongge Pan   +14 more
openalex   +1 more source

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu, Oliver Robinson, Christina M. Lill, Anna Matton, Raquel Puerta, Pilar Sanz, Merce Boada, Agustín Ruiz, Lefkos Middleton, for the Alzheimer's Disease Neuroimaging Initiative   +9 more
wiley   +1 more source

Programmable electric tweezers. [PDF]

Sci Adv
Chen Y, Tan H, Zhuang J, Xu Y, Zhang C, Feng J.   +5 more
europepmc   +1 more source

The MMP‐9/TIMP‐1 Ratio and Concentrations of Osteopontin Are Elevated in Cerebrospinal Fluid of People With Multiple Sclerosis and Decrease After Autologous Hematopoietic Stem Cell Transplantation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives To evaluate the utility of cerebrospinal fluid (CSF) biomarkers—matrix metalloproteinase‐9 (MMP‐9), tissue inhibitor of metalloproteinases‐1 (TIMP‐1), the MMP‐9/TIMP‐1 ratio, and osteopontin (OPN)—as indicators of blood–brain barrier (BBB) integrity and disease activity in people with relapsing–remitting multiple sclerosis (pwMS ...
Ivan Pavlovic, Ida Erngren, Kim Kultima, Anders Larsson, Malin Müller, Anna Wiberg, Joachim Burman   +6 more
wiley   +1 more source

Investigating Techniques to Reduce Flexor Tendon Rupture Risk During Manipulation for Dupuytren Contracture. [PDF]

J Hand Surg Glob Online
Joo PY, Luo X.
europepmc   +1 more source

Genetic manipulation [PDF]

Nature, 1976
openaire   +2 more sources

Manipulated Evidence? [PDF]

Deutsches Ärzteblatt international, 2014
Klaus, Strömer, Michael, Reusch
openaire   +2 more sources

Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Familial dysautonomia (FD) is a hereditary neurodevelopmental disorder caused by aberrant splicing of the ELP1 gene, leading to a tissue‐specific reduction in ELP1 protein expression. Preclinical models indicate that increasing ELP1 levels can mitigate disease manifestations.
Alejandra González‐Duarte, Lucy Norcliffe‐Kaufmann, Maria Luisa Cotrina, Zenith Khan, Kaia Dalamo, Patricio Millar Vernetti, Matthew Lawless, Elisabetta Morini, Monica Salani, Marla Weetall, Jana Narasimhan, Agostino G. Rocha, Susan A. Slaugenhaupt, Horacio Kaufmann   +13 more
wiley   +1 more source

Interactive imitation learning for dexterous robotic manipulation: challenges and perspectives-a survey. [PDF]

Front Robot AI
Welte E, Rayyes R.
europepmc   +1 more source